Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 22593457)

1.

Expression levels of thymidylate synthase, dihydropyrimidine dehydrogenase, and thymidine phosphorylase in patients with colorectal cancer.

Goto T, Shinmura K, Yokomizo K, Sakuraba K, Kitamura Y, Shirahata A, Saito M, Kigawa G, Nemoto H, Sanada Y, Hibi K.

Anticancer Res. 2012 May;32(5):1757-62.

PMID:
22593457
2.

Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.

Jensen SA, Vainer B, Witton CJ, Jørgensen JT, Sørensen JB.

Acta Oncol. 2008;47(6):1054-61. doi: 10.1080/02841860801942158.

PMID:
18607850
3.

Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.

Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C.

Oncology. 2006;70(5):366-77. Epub 2006 Dec 15.

PMID:
17179731
4.

Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors-correlation to tumor histopathology and clinical follow-up.

Lassmann S, Hennig M, Rosenberg R, Nährig J, Schreglmann J, Krause F, Poignee-Heger M, Nekarda H, Höfler H, Werner M.

Int J Colorectal Dis. 2006 Apr;21(3):238-47. Epub 2005 Aug 13.

PMID:
16132996
5.

Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.

Okumura K, Shiomi H, Mekata E, Kaizuka M, Endo Y, Kurumi Y, Tani T.

Oncol Rep. 2006 Apr;15(4):875-82.

PMID:
16525674
7.

Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.

Kinoshita M, Kodera Y, Hibi K, Nakayama G, Inoue T, Ohashi N, Ito Y, Koike M, Fujiwara M, Nakao A.

Anticancer Res. 2007 Mar-Apr;27(2):851-6.

8.

Prognostic markers in early-stage colorectal cancer: significance of TYMS mRNA expression.

Koumarianou A, Tzeveleki I, Mekras D, Eleftheraki AG, Bobos M, Wirtz R, Fountzilas E, Valavanis C, Xanthakis I, Kalogeras KT, Basdanis G, Pentheroudakis G, Kotoula V, Fountzilas G.

Anticancer Res. 2014 Sep;34(9):4949-62.

PMID:
25202077
10.

Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer.

Okumura K, Mekata E, Shiomi H, Naitoh H, Abe H, Endo Y, Kurumi Y, Tani T.

Cancer Chemother Pharmacol. 2008 Apr;61(4):587-94. Epub 2007 May 23.

PMID:
17520254
11.

Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.

Salonga D, Danenberg KD, Johnson M, Metzger R, Groshen S, Tsao-Wei DD, Lenz HJ, Leichman CG, Leichman L, Diasio RB, Danenberg PV.

Clin Cancer Res. 2000 Apr;6(4):1322-7.

12.

Molecular factors of 5-fluorouracil metabolism in colorectal cancer: analysis of primary tumor and lymph node metastasis.

Vallböhmer D, Kuramochi H, Shimizu D, Danenberg KD, Lindebjerg J, Nielsen JN, Jakobsen A, Danenberg PV.

Int J Oncol. 2006 Feb;28(2):527-33.

PMID:
16391809
13.

Comparative analysis of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in colorectal cancer and surrounding normal tissue.

Zimovjanova M, Sykora V, Novotny J, Gatek J, Petruzelka L, Holubec L, Pecen L.

Neoplasma. 2005;52(3):208-10.

PMID:
15875081
14.

Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression after administration of 5-fluorouracil to patients with colorectal cancer.

Mauritz R, van Groeningen CJ, Smid K, Jansen G, Pinedo HM, Peters GJ.

Int J Cancer. 2007 Jun 15;120(12):2609-12.

PMID:
17330233
15.

[Expression of mRNA levels of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in diffusely infiltrating colorectal cancer].

Ishibashi K, Sobajima J, Ohsawa T, Yokoyama M, Miyazaki T, Nakada H, Gonda T, Ishida H.

Gan To Kagaku Ryoho. 2007 Jul;34(7):1073-7. Japanese.

PMID:
17637543
16.

5-fluorouracil-related gene expression levels in primary colorectal cancer and corresponding liver metastasis.

Kuramochi H, Hayashi K, Uchida K, Miyakura S, Shimizu D, Vallbohmer D, Park S, Danenberg KD, Takasaki K, Danenberg PV.

Int J Cancer. 2006 Aug 1;119(3):522-6.

PMID:
16572420
17.

Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy.

Jakob C, Liersch T, Meyer W, Baretton GB, Schwabe W, Häusler P, Kulle B, Becker H, Aust DE.

Am J Surg Pathol. 2006 Sep;30(9):1169-74. Erratum in: Am J Surg Pathol. 2006 Nov;30(11):1489.

PMID:
16931962
18.
19.

Evaluation of 5-fluorouracil metabolic enzymes as predictors of response to adjuvant chemotherapy outcomes in patients with stage II/III colorectal cancer: a decision-curve analysis.

Shigeta K, Ishii Y, Hasegawa H, Okabayashi K, Kitagawa Y.

World J Surg. 2014 Dec;38(12):3248-56. doi: 10.1007/s00268-014-2738-1.

PMID:
25167895
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk